BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26417222)

  • 1. Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors.
    Mirzaie S; Monajjemi M; Hakhamaneshi MS; Fathi F; Jamalan M
    EXCLI J; 2013; 12():130-43. PubMed ID: 26417222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors.
    Asadollahi-Baboli M
    Mol Divers; 2016 Aug; 20(3):729-39. PubMed ID: 27209475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.
    Simeon S; Jongkon N; Chotpatiwetchkul W; Gleeson MP
    J Comput Aided Mol Des; 2019 Aug; 33(8):745-757. PubMed ID: 31494804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Assefa H; Kamath S; Buolamwini JK
    J Comput Aided Mol Des; 2003 Aug; 17(8):475-93. PubMed ID: 14703120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3d QSAR studies on a series of quinazoline derrivatives as tyrosine kinase (egfr) inhibitor: the k-nearest neighbor molecular field analysis approach.
    Noolvi MN; Patel HM
    J Basic Clin Pharm; 2010 Jun; 1(3):153-75. PubMed ID: 24825983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved 3D-QSAR prediction by multiple-conformational alignment: A case study on PTP1B inhibitors.
    Zhang X; Mao J; Li W; Koike K; Wang J
    Comput Biol Chem; 2019 Dec; 83():107134. PubMed ID: 31629257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents.
    Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H
    Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR Studies on a Series of 5-Arylidine-2, 4-Thiazolidinediones as Aldose Reductase Inhibitors: A Self-Organizing Molecular Field Analysis Approach.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Chem; 2010 Mar; ():. PubMed ID: 20218967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
    Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
    Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Basis of Amino Pyrimidine Derivatives for Inhibitory Activity of PKC-θ: 3D-QSAR and Molecular Docking Studies.
    Silakari O; Chand S; Bahia MS
    Mol Inform; 2012 Sep; 31(9):659-68. PubMed ID: 27477816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline analogues as cytotoxic agents; QSAR, docking, and
    Emami L; Sabet R; Khabnadideh S; Faghih Z; Thayori P
    Res Pharm Sci; 2021 Oct; 16(5):528-546. PubMed ID: 34522200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.